GFPT2: The Glutamine:fructose 6-Phosphate Amidotransferase 2 (G9945)
GFPT2: The Glutamine:fructose 6-Phosphate Amidotransferase 2
Glutamine:fructose 6-phosphate amidotransferase 2 (GFPT2) is a gene that encodes a protein in the amino acid transporter family. This protein is involved in the transport of amino acids across cell membranes and is a key player in the regulation of cell signaling pathways. GFPT2 has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
GFPT2 is a protein that plays a crucial role in the regulation of cellular signaling pathways. It is a key transporter for the amino acid glutamine, which is a key signaling molecule in many cellular processes. GFPT2 is involved in the transport of glutamine across the cell membrane and is essential for the proper functioning of many cellular signaling pathways.
GFPT2 has been shown to be involved in the regulation of many cellular signaling pathways, including cell proliferation, apoptosis, and inflammation. For example, studies have shown that GFPT2 is involved in the regulation of cell proliferation and has been shown to play a role in the development of cancer. Additionally, GFPT2 has been shown to be involved in the regulation of apoptosis, which is the process by which cells die, and has been linked to the development of neurodegenerative diseases.
GFPT2 has also been shown to be involved in the regulation of inflammation, which is a critical aspect of many diseases, including cancer and neurodegenerative diseases. Studies have shown that GFPT2 is involved in the regulation of inflammation and has been shown to play a role in the development of autoimmune disorders.
In addition to its role in cellular signaling pathways, GFPT2 has also been shown to be involved in the regulation of many other cellular processes, including cell adhesion, migration, and the transport of nutrients and waste products.
GFPT2 has also been identified as a potential drug target and biomarker for several diseases. For example, studies have shown that GFPT2 is involved in the regulation of cancer cell growth and has been shown to play a role in the development of many types of cancer. Additionally, GFPT2 has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
GFPT2 has also been shown to be involved in the regulation of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis. Studies have shown that GFPT2 is involved in the regulation of the immune system and has been shown to play a role in the development of these disorders..
In conclusion, GFPT2 is a protein that plays a crucial role in the regulation of cellular signaling pathways and has been shown to be involved in the regulation of many cellular processes, including cell proliferation, apoptosis, inflammation, and the transport of nutrients and waste products . GFPT2 has also been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of GFPT2 in these diseases and to develop effective treatments.
Protein Name: Glutamine-fructose-6-phosphate Transaminase 2
Functions: Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins
The "GFPT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GFPT2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GFRA1 | GFRA2 | GFRA3 | GFRA4 | GFRAL | GFUS | GGA1 | GGA2 | GGA3 | GGACT | GGCT | GGCX | GGH | GGN | GGNBP1 | GGNBP2 | GGPS1 | GGT1 | GGT2P | GGT3P | GGT5 | GGT6 | GGT7 | GGT8P | GGTA1 | GGTLC1 | GGTLC2 | GGTLC3 | GH1 | GH2 | GHDC | GHITM | GHR | GHRH | GHRHR | GHRL | GHRLOS | GHSR | GID4 | GID8 | GIGYF1 | GIGYF2 | GIHCG | GIMAP1 | GIMAP1-GIMAP5 | GIMAP2 | GIMAP3P | GIMAP4 | GIMAP5 | GIMAP6 | GIMAP7 | GIMAP8 | GIMD1 | GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L
